Advanced search
Publication Cover
Leukemia & Lymphoma Volume 37, 2000 - Issue 1-2
Submit an article Journal homepage
46
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Prognostic Significance of Serum Soluble Interleukin-2 Receptor Level in Non-Hodgkin's Lymphoma: A Single Center Study in Japan

Natsu Kono Department of Hematology, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan
,
Yoshinobu Kanda Department of Hematology, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, JapanCorrespondence[email protected]
,
Rie Yamamoto Department of Hematology, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan
,
Aki Chizuka Department of Hematology, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan
,
Miyuki Suguro Department of Hematology, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan
,
Tamae Hamaki Department of Hematology, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan
,
Chiaki Arai Department of Hematology, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan
,
Tomohiro Matsuyama Department of Hematology, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan
,
Naoki Takezako Department of Hematology, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan
,
Akiyoshi Miwa Department of Hematology, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan
&
Atsushi Togawa Department of Hematology, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan
 show all
Pages 151-156 | Published online: 01 Jul 2009

References

  • Farrar J.J., Benjamin W.R., Hilfiker M.L., et al. The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antigen-forming B cell response. Immunological Reviews 1982; 63: 129–166
  • Gills S. Interleukin 2: Biology and biochemistry. Journal of Clinical Immunology 1983; 3: 1–13
  • Robb R.J., Munck A., Smith K.A. T cell growth factor receptors: Quantitation, specificity, and biological relevance. Journal of Experimental Medicine 1981; 154: 1455–1474
  • Waldmann T.A., Goldman C.K., Robb R.J., et al. Expression of interleukin 2 receptors on activated human B cells. Journal of Experimental Medicine 1984; 160: 1450–1466
  • Korsmeyer S.J., Greene W.C., Cossman J., et al. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairry cell leukemia. Proceedings of National Academy of Science 1983; 80: 4522–4526
  • Depper J.M., Leonard W.J., Kronke M., et al. Augmented T-cell growth factor receptor expression in HTLV-1-infected human leukemia T-cells. Journal of Immunology 1984; 133: 1691–1695
  • Rubin L.A., Kurmann C.C., Fitz M.E., et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. Journal of Immunology 1985; 135: 3172–3177
  • Rubin L.A., Nelson D.L. The soluble Interleukin-2 receptor: Biology, function, and clinical application. Annals of Internal Medicine 1990; 113: 619–627
  • Wagner D.K., Kiwanuka J., Edwards B.K., et al. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival. Journal of Clinical Oncology 1987; 5: 1262–1274
  • Pui C.H., Ip S.H., Kung P., et al. High serum interleukin-2 receptor levels are related to advanced disease and a poor outcome in childhood non-Hodgkin's lymphoma. Blood 1987; 82: 2169–2174
  • Stasi R., Zinzani P.L., Galieni P., et al. Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Cancer 1994; 74: 1792–1800
  • Barak V., Ginzburg M., Kalickman I., Polliack A. Serum soluble IL-2 receptor levels are associated with clinical disease status and grade in lymphoma and lymphocyte leukemia. Leukemia & Lymphoma 1992; 7: 431–438
  • Fisher R.I., Gaynor E.R., Dahlberg S., et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New England Journal of Medicine 1993; 328: 1002–1006
  • Velasquez W.S., McLaughlin P., Tucker S., et al. ESHAP - An Effective chemothrapy Regimen in Refractory and Relapsing Lymphoma: A 4-Year Follow-Up Study. Journal of Clinical Oncology 1994; 12: 1169–1176
  • The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. New England Journal of Medicine 1993; 329: 987–994
  • Hermans J., Krol A.D., van Groningen K., et al. International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades. Blood 1995; 86: 1460–1463

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.